This business information is not released now.


Back
This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.


BioMedCore, Inc.
【Field/Business】
Drug discovery support/Contract service
Pharmaceutical/Drug Discovery
Food/Beverage
last update:2017/5/10
Profile

Delegates :
Takuro Wakabayashi


Incorporated :
December  27 , 2005

Paid in Capital :
92 Million yen  

Employees :
5 人

Address :
LVP 1-109 Ono-cho 75-1, Tsurumi-ku, Yokohama-shi KANAGAWA
〒230-0046

TEL/FAX :
+81-45-501-1714 / +81-45-501-1715

URL:
www.libmec.com

Attachment :

Mission/Background :
BioMedCore was founded in the end of 2005 as a spined venture from Tokai univ. with IP on MCL(Mannose Coated Liposome)enable to perform as a very strong vaccine adjuvant as well as DDS carrier. Our mission is to contribute human's healthcare with our liposome DDS dedicated technologies. We will commit excellent service from initial liposomal forlumating stage to GMP sample drug production.
On the other hand, we execute sales and commercial production of liposomal medical nutrition supplement in our own facility.

Technology & Business
We BioMedCore, Inc. perform liposomal drug development, liposome dedicated CDMO, liposomal supplement nutrition business used innovative ‘LibMec method’ GMP eligible liposome production technology.
Libmec is patented enabling to manufacture sterilized and uniform liposome regardless of any particle size, excellent reproducibility, consistently scale up with ease.
We move forward R&D of liposome DDS drug pile lines collaborated with some academia, like as retinal disease therapeutic eye drop, cancer liposomal vaccine.
We’d recently started strategic alliance with Taiwan pharmaceutical company to provide GMP drug for clinical trial use. This collaboration will drive seamless value to clients from initial liposomal formulation stage to the final.
On the other hand, development of unique liposomal medical supplement featured bioavailability immune activity improvement and supply them to the medical oriented commercial market is another pillar of our business.

Products & Service
Products & Service Name
Stage
Outline
Milestone
Liposomal drug oriented CDMO
Service/Marketing
From initial formulation to GMP drug production service
New opportunity attainment
Retinal disease treatment liposomal DDS eye drop pile pine development
Preclinical
Retinal disease treatment as an unmet need with noninvasive therapy used special featured liposome
Complete preclinical, moving forward to Clinical stage
Liposomal nutrition products as medical supplement
Launched
Large scale production in our own facility, proceed new products development.
Commercial launch of new product in this year








Highlights
Recently announced new strategic alliance with Taiwan pharmaceutical company to enforce CDMO entire service. This partnership will drive liposome sample drug for injection.
Hot news

Alliance strategy
Looking for a now alliance of Co-R&D in several liposomal DDS drug programs.
Furthermore, joint business of functional liposomal nutrition consolidated with partner's attractive food additives and our liposomal production technology.


 
This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.